Report Description Table of Contents How Are Rising Hospital Utilization, Safety Innovations, and Advanced Catheter Designs Driving the Peripheral Intravenous Catheters Market? According to Strategic Market Research, the Global Peripheral Intravenous Catheters Market was valued at USD 4.75 billion in 2025 and is projected to reach USD 7.36 billion by 2032, expanding at a CAGR of 6.47% during 2026–2032. Widespread use of peripheral intravenous catheters (PIVCs) for medication administration, fluid therapy, and hospital treatment is supporting recurring demand. A published international hospital study estimated more than 1 billion PIVC insertions worldwide annually, while approximately 59% of hospitalized patients surveyed had a PIVC in place. These historical clinical findings demonstrate the substantial utilization of peripheral IV catheters across healthcare facilities. High clinical utilization is supporting continued investment in PIVC manufacturing capacity. In January 2025, BD announced additional investments in U.S. manufacturing, including expanded IV catheter production capabilities at its Utah facility. The company also reported that previous manufacturing improvements had increased annual IV catheter output by more than 40 million units. Its established Nexiva, Insyte Autoguard, and AccuCath product portfolios reflect continued demand for conventional and safety-engineered peripheral IV catheters. Difficult venous access and extended-duration therapy are creating opportunities for specialized PIVCs. In October 2026, B. Braun launched its Introcan Safety 2 Deep Access IV Catheter, following FDA clearance in September 2024. The product addresses patients requiring deeper peripheral venous access and longer treatment periods, highlighting growing manufacturer investment in specialized catheter designs that support reliable vascular access and reduce repeated insertion requirements. Safety-engineered and integrated catheter systems are strengthening market competition. In August 2026, MedSource Labs introduced its ClearSafe Comfort Closed System, following FDA 510(k) clearance in July 2026. The product incorporates needle protection, blood control, and an integrated extension set. Its introduction reflects increasing emphasis on healthcare worker safety, reduced blood exposure, and integrated peripheral IV catheter solutions. Closed-system catheters and longer peripheral access devices are emerging as important areas of product development. Manufacturers are expanding portfolios designed to support safer vascular access and extended catheter use. B. Braun's Introcan Safety 2 Deep Access and MedSource Labs' ClearSafe Comfort Closed System demonstrate growing emphasis on integrated safety, blood control, and reduced catheter handling. These developments support product differentiation across hospital and acute-care applications. The Peripheral Intravenous Catheters Market is projected to generate approximately USD 2.61 billion in additional annual revenue by 2032, supported by recurring hospital utilization, safety-engineered catheter adoption, specialized vascular access products, and manufacturing expansion. BD, B. Braun, MedSource Labs, Terumo, ICU Medical, and Nipro represent established and emerging competitors, with product safety, integrated designs, and difficult-access applications shaping future market opportunities. Which Peripheral Intravenous Catheter Segments Are Leading Market Adoption and Emerging as the Strongest Commercial Opportunities? By Product Type: Needle Protection and Closed Systems Reshape Hospital Purchasing Leading Subsegment: Safety Peripheral IV Catheters Safety peripheral intravenous catheters (PIVCs) dominate the Peripheral Intravenous Catheter Market, accounting for an estimated 42% market share, valued at USD 1.995 billion in 2025. Equipped with integrated needle-protection mechanisms, safety PIVCs help minimize needlestick injuries, reduce blood exposure, and improve vascular access safety for healthcare professionals and patients. Increasing adoption of safety-engineered devices across hospitals and outpatient facilities supports continued expansion at a CAGR of 7.20% during 2026–2032, with the market projected to reach approximately USD 3.25 billion by 2032. Fastest-Growing Subsegment: Integrated/Closed-System Peripheral IV Catheters Integrated/closed-system peripheral IV catheters combine a short peripheral catheter, extension tubing, clamp, and needleless injection port into a single preassembled vascular access device, supporting safer and more efficient intravenous therapy. Within the Peripheral Intravenous Catheter Market, integrated/closed-system devices accounted for 26% of the global market, valued at USD 1.235 billion in 2025. The category is projected to record the fastest CAGR of approximately 7.78% during 2026–2032, reaching USD 2.09 billion by 2032, supported by infection-prevention initiatives and hospital adoption of closed vascular access systems. By Catheter Material: Polyurethane Flexibility Supports Patient Comfort and Vascular Compatibility Leading and Fastest-Growing Subsegment: Polyurethane (PU) Catheters Polyurethane catheters lead the Peripheral Intravenous Catheter Market, accounting for an estimated 65% market share, equivalent to USD 3.088 billion in 2025. With a projected CAGR of 7.10% during 2026–2032, the market value of polyurethane catheters is expected to reach approximately USD 4.99 billion by 2032. Polyurethane (PU) is widely preferred in peripheral intravenous catheter manufacturing because of its thermoplastic properties, flexibility, mechanical strength, and ability to soften at body temperature, supporting patient comfort, vascular compatibility, and reliable catheter performance during intravenous therapy. By Gauge Size: Routine Infusion Versatility and Smaller-Vein Access Shape Demand Leading Subsegment: 20G Catheters The 20G catheter category accounted for the largest estimated market share of 46%, valued at USD 2.185 billion in 2025, and is projected to reach approximately USD 3.39 billion by 2032, growing at a CAGR of 6.50% during 2026–2032. Widely recognized by its pink color coding, the 20-gauge peripheral intravenous catheter offers an effective balance between adequate infusion flow rates and reduced vessel trauma. Its versatility across routine intravenous medication administration, fluid therapy, and hospital procedures supports widespread clinical adoption. Fastest-Growing Subsegment: 22G Catheters The 22-gauge (22G) peripheral intravenous catheter, identified by its blue color code, has an external diameter of approximately 0.9 mm and a typical flow rate of 36 mL per minute, supporting controlled intravenous fluid administration, medication delivery, and vascular access in patients with smaller veins. The 22G catheter category accounted for 22% of the global market, valued at USD 1.045 billion in 2025, and is projected to grow at the fastest CAGR of 7.60%, reaching approximately USD 1.75 billion by 2032. By Application: Recurring Medication Delivery and Diagnostic Access Sustain Catheter Consumption Leading Subsegment: Medication Administration Medication administration dominates the Peripheral Intravenous Catheter Market, accounting for approximately 55% market share and USD 2.613 billion in 2025. The application is projected to grow at a CAGR of 6.80% during 2026–2032, reaching USD 4.14 billion by 2032. Peripheral intravenous catheters provide direct access to systemic circulation for administering antibiotics, analgesics, and other therapeutic agents. Widespread utilization across hospitals, emergency departments, and outpatient facilities supports market expansion, particularly through increasing intravenous treatment volumes and recurring catheter replacements. Fastest-Growing Subsegment: Other Applications Other applications, including selected blood sampling and diagnostic access procedures, represent approximately 4% of market revenue, equivalent to USD 0.190 billion in 2025, and are projected to register the fastest CAGR of 8.76% during 2026–2032, reaching approximately USD 0.342 billion by 2032. Opportunities arise from selected multipurpose peripheral access workflows and technologies that allow appropriate blood sampling through existing access devices. However, clinical suitability and sampling protocols influence actual utilization, making this category more specialized than routine medication administration. By End User: Hospital Procurement Meets Expanding Outpatient Infusion Networks Leading Subsegment: Hospitals Hospitals dominate the Peripheral Intravenous Catheter Market, accounting for approximately 75% of the global market, valued at USD 3.563 billion in 2025. The hospital category is projected to expand at a CAGR of 6.00% during 2026–2032, reaching USD 5.36 billion by 2032. Hospitals play a critical role throughout the PIVC lifecycle, encompassing catheter selection, insertion, maintenance, infection surveillance, and removal. High patient admissions, frequent intravenous medication administration, and continuous catheter replacement support substantial PIVC utilization across emergency departments, intensive care units, and inpatient wards. Fastest-Growing Subsegment: Clinics and Home Healthcare Settings Clinics and home healthcare settings accounted for an estimated 12% of the Peripheral Intravenous Catheter Market, valued at USD 0.570 billion in 2025, and are projected to grow at the fastest CAGR of 8.14%, reaching USD 0.986 billion by 2032. Growth is supported by the increasing shift toward outpatient infusion therapy, home-based medication administration, and community healthcare services. Expanding ambulatory care networks and greater adoption of PIVCs for short-term intravenous treatments are strengthening their role in decentralized patient care. By Geography: North American Safety Investment and Asian Hospital Expansion Shape Revenue Leading Regional Segment: North America North America leads the Peripheral Intravenous Catheter Market, accounting for an estimated 39% share, valued at USD 1.853 billion in 2025. The regional market is projected to grow at a CAGR of 5.70% during 2026–2032, reaching approximately USD 2.73 billion by 2032. Peripheral intravenous catheters are used extensively across hospitals and acute care facilities, supported by advanced healthcare infrastructure, high inpatient admissions, and widespread clinical utilization for medication administration, intravenous fluid therapy, and blood transfusions. Fastest-Growing Regional Segment: Asia-Pacific The Asia-Pacific Peripheral Intravenous Catheter Market is experiencing rapid adoption, positioning the region as a key contributor to global market expansion. Asia-Pacific accounted for approximately 25% of the global market, valued at USD 1.188 billion in 2025, and is projected to reach USD 2.05 billion by 2032, growing at the fastest regional CAGR of 8.10% during 2026–2032. Expanding hospital infrastructure, rising surgical procedures, increasing hospitalization rates, and improved access to intravenous therapies are accelerating PIVC utilization across China, India, and Southeast Asia. What Are the Key Factors Driving the Peripheral Intravenous Catheters Market? Increasing Hospital Admissions and Surgical Procedures The rising number of hospital admissions, emergency visits, and surgical procedures is a major factor supporting the peripheral intravenous catheters market. Peripheral IV catheters are routinely used to administer medications, fluids, antibiotics, and anesthesia-related treatments. Their frequent use across emergency departments, operating rooms, and inpatient wards creates recurring procurement requirements. Since these devices are typically intended for single-patient use, patient turnover and clinically necessary catheter replacements contribute to consistent consumption. Hospitals also prioritize reliable vascular access to support timely treatment and reduce interruptions in patient care. Rising Chronic Disease Burden and Intravenous Treatment Requirements The increasing prevalence of cancer, cardiovascular diseases, diabetes, and serious infections is contributing to more frequent intravenous treatment across healthcare facilities. Patients hospitalized for these conditions often require antibiotics, hydration, pain management, and supportive medications delivered through peripheral catheters. Older patients may require repeated hospital treatment and have more challenging venous access, influencing catheter selection. The expansion of specialized treatment services and infusion clinics further supports catheter utilization, particularly for short-duration therapies where peripheral intravenous access is clinically appropriate. Greater Adoption of Safety-Engineered Catheters Healthcare facilities are placing greater emphasis on preventing needlestick injuries, limiting blood exposure, and reducing complications associated with peripheral intravenous access. This is encouraging the adoption of safety-engineered catheters featuring automatic needle protection, integrated blood-control mechanisms, and improved stabilization designs. Hospitals are also considering catheter failure, repeated insertion attempts, nursing time, and patient discomfort when evaluating products. These purchasing priorities are supporting the transition from conventional devices toward integrated and closed-system catheters, particularly in healthcare facilities with established infection-prevention and occupational safety programs. Expansion of Outpatient and Home-Based Intravenous Care The shift toward outpatient treatment, ambulatory surgery, and home healthcare is increasing the use of peripheral intravenous catheters outside traditional hospital wards. Short-duration antibiotic therapy, hydration, diagnostic procedures, and perioperative medication administration are common applications in these settings. Healthcare providers are seeking devices that allow straightforward insertion, secure connections, and reliable medication delivery while supporting efficient treatment workflows. Investment in ambulatory facilities and efforts to shorten hospital stays are creating additional purchasing opportunities for catheter manufacturers, particularly those offering safety-focused products suitable for decentralized care. Which Companies Are Shaping Competition and Product Innovation in the Peripheral Intravenous Catheters Market? Becton, Dickinson and Company (BD) — Safety-Engineered Catheters and Hospital Vascular Access BD is a major supplier of peripheral intravenous catheters, supported by its established hospital distribution network and safety-engineered vascular access portfolio. Its BD Insyte Autoguard and BD Nexiva product families address needle protection, blood exposure management, and integrated catheter access requirements. BD's competitive position is strengthened by its ability to supply high-volume hospital customers with standardized vascular access products. Its integrated catheter designs also support healthcare facilities seeking to streamline insertion procedures and reduce unnecessary device manipulation. BD's commercial opportunities are closely linked to institutional safety purchasing policies, clinical training, and the adoption of higher-specification peripheral IV systems. B. Braun SE — Integrated IV Systems and Clinical Workflow Efficiency B. Braun SE maintains an important position in peripheral intravenous access through its Introcan Safety and related catheter products. The company supplies safety-engineered devices designed for routine peripheral venous access, alongside a broader portfolio covering infusion therapy, connection systems, and hospital consumables. Its competitive advantage lies in combining peripheral catheter products with complementary infusion equipment and accessories. This approach supports hospital procurement programs seeking compatible products from established suppliers. B. Braun's catheter technologies emphasize needle protection, practical insertion workflows, and blood-control features across selected product configurations, supporting its presence in safety-conscious healthcare markets. Other Important Companies and Their Market Roles Terumo Corporation: Supplies peripheral intravenous catheters, including the SURFLO product family, serving hospitals and clinical facilities that require reliable vascular access for routine infusion procedures. ICU Medical, Inc.: Participates in the peripheral IV catheter market through its Jelco and ViaValve product offerings, with a focus on catheter insertion, blood control, and integrated intravenous therapy solutions. Analyst Commentary: How Can Lower Catheter Failure and Nursing Workload Strengthen Supplier Value? In the peripheral intravenous catheters market, competitive advantage increasingly depends on reducing catheter failure, repeat insertions, and nursing workload rather than competing solely on unit price. Manufacturers that demonstrate measurable clinical benefits and lower overall treatment costs are better positioned to secure long-term hospital procurement contracts and premium product positioning. Peripheral Intravenous Catheters Market Report Coverage Table Report Attribute Details Forecast Period 2026 – 2032 Market Size Value in 2025 USD 4.75 Billion Revenue Forecast in 2032 USD 7.36 Billion Overall Growth Rate CAGR of 6.47% (2026 – 2032) Base Year for Estimation 2025 Historical Data 2019 – 2024 Unit USD Million/Billion, CAGR (2026 – 2032) Segmentation By Product Type, By Catheter Material, By Gauge Size, By Application, By End User, By Geography By Product Type Conventional Peripheral IV Catheters, Safety Peripheral IV Catheters, Integrated/Closed-System Peripheral IV Catheters By Catheter Material Polyurethane Catheters, Polytetrafluoroethylene Catheters, Other Catheter Materials By Gauge Size 18G Catheters, 20G Catheters, 22G Catheters, Other Gauge Sizes By Application Medication Administration, Fluid and Electrolyte Administration, Blood Transfusion, Other Applications By End User Hospitals, Ambulatory Surgical Centers, Clinics and Home Healthcare Settings By Region North America, Europe, Asia-Pacific, Latin America, Middle East & Africa Country Scope U.S., Canada, UK, Germany, France, Italy, China, Japan, South Korea, India, Brazil, Mexico, Saudi Arabia, UAE, South Africa Market Drivers Recurring hospital demand for peripheral IV access, adoption of safety-engineered catheters, demand for reduced blood exposure, expansion of integrated closed-system products, specialized catheter development for difficult venous access and longer treatment periods Customization Option Available upon request Frequently Asked Question About This Report Q1. What factors are driving demand across the market? A1. Demand is supported by high hospital utilization, increasing intravenous treatments, surgical procedures, and recurring catheter replacement requirements. Growing adoption of safety-engineered devices is also strengthening hospital procurement. Q2. What are the latest innovations shaping the industry? A2. Manufacturers are introducing closed-system catheters, automatic needle-protection mechanisms, integrated blood-control features, and deep-access designs. These innovations aim to improve patient safety and reduce repeated insertion attempts. Q3. Why are integrated catheter systems gaining importance in the market? A3. Integrated and closed-system catheters reduce device handling and support safer intravenous access. The segment is projected to grow at a CAGR of 7.78% during 2026–2032, supported by hospital infection-prevention and safety initiatives. Q4. Which catheter size is gaining the fastest adoption in the industry? A4. The 22G catheter segment is projected to record the fastest gauge-based CAGR of 7.60% during 2026–2032. Its suitability for patients with smaller or fragile veins supports increasing clinical utilization. Q5. How are specialized catheter materials influencing the market? A5. Polyurethane catheters lead with an estimated 65% share in 2025. Their flexibility, mechanical strength, and ability to soften at body temperature support reliable intravenous access and patient comfort. Q6. Which healthcare settings are creating new opportunities in the industry? A6. Clinics and home healthcare settings are projected to grow at a CAGR of 8.14% during 2026–2032. Outpatient infusion services, short-duration intravenous treatments, and expanding community healthcare networks are supporting adoption. Q7. Which region is expected to record the fastest growth in the market? A7. Asia-Pacific is projected to record the fastest regional CAGR of 8.10% during 2026–2032. Growth is supported by hospital infrastructure expansion, increasing surgical procedures, and wider access to intravenous therapies across China, India, and Southeast Asia. Sources: Becton, Dickinson and Company – Reported an Increase of More Than 40 Million IV Catheters in Annual Manufacturing Output Following Its 2024 Production Improvements BD – U.S. IV Catheter Manufacturing Expansion and Additional Annual Production Capacity B. Braun Medical – Launched Introcan Safety 2 Deep Access IV Catheter on October 1, 2026, Targeting Difficult Venous Access and Extended Therapy B. Braun – Introcan Safety 2 Deep Access IV Catheter Commercial Launch U.S. FDA – Cleared Introcan Safety 2 IV Catheter Under K241845 on July 26, 2024 FDA – Introcan Safety 2 IV Catheter: Official 510(k) Clearance Record MedSource Labs – Introduced ClearSafe Comfort Closed System on August 18, 2026, Combining a Safety Peripheral IV Catheter With an Integrated Extension Set MedSource Labs – ClearSafe Comfort Closed-System Peripheral IV Catheter Launch U.S. FDA – Granted ClearSafe Closed System 510(k) Clearance on July 10, 2026, Under Clearance Number K261041 FDA – MedSource ClearSafe Closed System: Regulatory Clearance Record BD – Confirms Nexiva, Insyte Autoguard, and AccuCath Ace Within Its Peripheral IV Catheter Portfolio BD – Peripheral IV Catheter Portfolio, Materials, Safety Features, and Configurations ICU Medical – Lists ViaValve Safety IV Catheters With Blood Control in Sizes From 14G to 24G ICU Medical – Vascular Access Product Catalogue: ViaValve and Peripheral IV Catheters Terumo – Offers SURFLO ETFE Peripheral IV Catheters Across 14G, 16G, 18G, 20G, 22G, and 24G Sizes Terumo – SURFLO ETFE IV Catheter Portfolio and Available Gauge Sizes. Table of Contents - Global Peripheral Intravenous Catheters Market Report (2026–2032) Executive Summary Market Overview Market Attractiveness by Product Type, Catheter Material, Gauge Size, Application, End User, and Region Strategic Insights from Key Executives (CXO Perspective) Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Summary of Market Segmentation by Product Type, Catheter Material, Gauge Size, Application, End User, and Region Market Share Analysis Leading Players by Revenue and Market Share Market Share Analysis by Product Type, Catheter Material, Gauge Size, Application, and End User Investment Opportunities in the Peripheral Intravenous Catheters Market Key Developments and Innovations Mergers, Acquisitions, and Strategic Partnerships High-Growth Segments for Investment Opportunities in Safety-Engineered Catheters, Integrated/Closed-System Catheters, Advanced Catheter Materials, Difficult Venous Access Solutions, and Outpatient Vascular Access Manufacturing Capacity Expansion and Product Portfolio Development Market Introduction Definition and Scope of the Study Market Structure and Key Findings Overview of Top Investment Pockets Strategic Importance of Peripheral Intravenous Catheters in Medication Administration, Fluid and Electrolyte Therapy, Blood Transfusion, and Hospital Care Role of Safety-Engineered Devices, Integrated Catheter Systems, and Specialized Vascular Access Products Research Methodology Research Process Overview Primary and Secondary Research Approaches Market Size Estimation and Forecasting Techniques Data Triangulation and Segment-Level Forecasting Approach Market Dynamics Key Market Drivers Challenges and Restraints Impacting Growth Emerging Opportunities for Stakeholders Impact of Regulatory and Public Health Factors Role of Hospital Admissions, Surgical Procedures, and Intravenous Treatment Requirements in Market Expansion Needlestick Injury Prevention, Blood Exposure Reduction, Catheter Failure, and Vascular Access Safety Trends Impact of Outpatient Infusion Therapy and Home Healthcare on Peripheral IV Catheter Adoption Manufacturing Expansion and Advanced Catheter Design Developments During 2025–2026 Global Peripheral Intravenous Catheters Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Product Type: Conventional Peripheral IV Catheters Safety Peripheral IV Catheters Integrated/Closed-System Peripheral IV Catheters Market Analysis by Catheter Material: Polyurethane (PU) Catheters Polytetrafluoroethylene (PTFE) Catheters Other Catheter Materials Market Analysis by Gauge Size: 18G Catheters 20G Catheters 22G Catheters Other Gauge Sizes, Including 14G, 16G, 24G, and 26G Market Analysis by Application: Medication Administration Fluid and Electrolyte Administration Blood Transfusion Other Applications, Including Suitable Blood Sampling and Diagnostic Access Procedures Market Analysis by End User: Hospitals Ambulatory Surgical Centers Clinics and Home Healthcare Settings Market Analysis by Region: North America Europe Asia-Pacific Latin America Middle East & Africa Regional Market Analysis North America Peripheral Intravenous Catheters Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Product Type, Catheter Material, Gauge Size, Application, and End User Country-Level Breakdown: United States Canada Mexico Europe Peripheral Intravenous Catheters Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Product Type, Catheter Material, Gauge Size, Application, and End User Country-Level Breakdown: Germany United Kingdom France Italy Spain Rest of Europe Asia-Pacific Peripheral Intravenous Catheters Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Product Type, Catheter Material, Gauge Size, Application, and End User Country-Level Breakdown: China India Japan South Korea Australia Rest of Asia-Pacific Latin America Peripheral Intravenous Catheters Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Product Type, Catheter Material, Gauge Size, Application, and End User Country-Level Breakdown: Brazil Mexico Rest of Latin America Middle East & Africa Peripheral Intravenous Catheters Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Product Type, Catheter Material, Gauge Size, Application, and End User Country-Level Breakdown: Saudi Arabia United Arab Emirates South Africa Rest of Middle East & Africa Competitive Intelligence and Benchmarking Leading Key Players: Becton, Dickinson and Company (BD) B. Braun SE Terumo Corporation ICU Medical, Inc. MedSource Labs Nipro Corporation Smiths Medical Vygon S.A. Teleflex Incorporated Angiplast Pvt. Ltd. Competitive Landscape and Strategic Insights Benchmarking Based on Product Safety, Catheter Materials, Integrated Designs, Blood Control, Product Availability, and Regional Presence Supplier Qualification and Regulatory Compliance Capability Analysis Safety-Engineered Peripheral IV Catheter Portfolio Positioning Integrated/Closed-System Catheter Product Development and Competitive Positioning Advanced Catheter Materials and Difficult Venous Access Solutions Manufacturing Capacity Expansion and Product Innovation Developments During 2025–2026 Appendix Abbreviations and Terminologies Used in the Report References and Sources List of Tables Market Size by Product Type, Catheter Material, Gauge Size, Application, End User, and Region (2026–2032) Regional Market Breakdown by Segment Type (2026–2032) Country-Level Market Analysis Across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa Competitive Benchmarking of Leading Vendors Product Comparison of Conventional, Safety, and Integrated/Closed-System Peripheral IV Catheters Catheter Material and Gauge Size Adoption Trends Manufacturing Expansion, Regulatory Clearance, and Product Launch Developments During 2025–2026 List of Figures Market Drivers, Challenges, Opportunities, and Restraints Regional Market Snapshot Competitive Landscape by Market Share Growth Strategies Adopted by Key Players Market Share by Product Type, Catheter Material, Gauge Size, Application, and End User (2025 vs. 2032) Global Peripheral Intravenous Catheters Ecosystem and Value Chain Analysis Safety-Engineered and Integrated Catheter Technology Trends